ReneBlackstockofficial

PFE ANALYSIS, LONGER TERM, FUNDAMENTAL/TECHNICAL

NYSE:PFE   Pfizer, Inc
Financial Highlights
Fiscal Year
Fiscal Year Ends Dec 30, 2019
Most Recent Quarter ( mrq ) Mar 28, 2020
Profitability
Profit Margin 31.17%
Operating Margin ( ttm ) 29.36%
Management Effectiveness
Return on Assets ( ttm ) 5.78%
Return on Equity ( ttm ) 25.41%
Income Statement
Revenue ( ttm ) 50.66B
Revenue Per Share ( ttm ) 9.13
Quarterly Revenue Growth (yoy) -8.30%
Gross Profit ( ttm ) 41.74B
EBITDA 20.53B
Net Income Avi to Common ( ttm ) 15.78B
Diluted EPS ( ttm ) 2.80
Quarterly Earnings Growth (yoy) -12.40%
Balance Sheet
Total Cash ( mrq ) 10.36B
Total Cash Per Share ( mrq ) 1.87
Total Debt ( mrq ) 52.29B
Total Debt/Equity ( mrq ) 80.03
Current Ratio ( mrq ) 1.02
Book Value Per Share ( mrq ) 11.71
Cash Flow Statement
Operating Cash Flow ( ttm ) 14.02B
Levered Free Cash Flow ( ttm ) 19.44B

Trading Information
Stock Price History
Beta (5Y Monthly) 0.71
52-Week Change 3 -9.57%
S&P500 52-Week Change 3 8.60%
52 Week High 3 44.56
52 Week Low 3 27.88
50-Day Moving Average 3 37.33
200-Day Moving Average 3 36.75
Share Statistics
Avg Vol (3 month) 3 30.54M
Avg Vol (10 day) 3 28.54M
Shares Outstanding 5 5.55B
Float 5.55B
% Held by Insiders 1 0.04%
% Held by Institutions 1 72.56%
Shares Short (May 14, 2020) 4 52.59M
Short Ratio (May 14, 2020) 4 2.33
Short % of Float (May 14, 2020) 4 0.95%
Short % of Shares Outstanding (May 14, 2020) 4 0.95%
Shares Short (prior month Apr 14, 2020) 4 44.31M
Dividends & Splits
Forward Annual Dividend Rate 4 1.52
Forward Annual Dividend Yield 4 3.98%
Trailing Annual Dividend Rate 3 1.46
Trailing Annual Dividend Yield 3 3.82%
5 Year Average Dividend Yield 4 3.54
Payout Ratio 4 52.14%
Dividend Date 3 Jun 04, 2020
Ex-Dividend Date 4 May 06, 2020
Last Split Factor 2 3:1
Last Split Date 3 Jun 30, 1999

Key Executives
Name Title Pay Exercised Year Born
Dr . Albert Bourla D.V.M., DVM, Ph .D. Chairman & CEO 5.84M 2.12M 1962
Mr. John D. Young Group Pres & Chief Bus. Officer 3.36M 3.83M 1965
Mr. Frank A. D'Amelio CFO & EVP of Global Supply & Bus. Operations 3.84M 8.47M 1958
Dr . Mikael Dolsten Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical 3.66M 7.93M 1959
Ms . Jennifer B. Damico Sr. VP, Controller & Principal Accounting Officer N/A N/A 1968


I am not a financial advisor and i do not recommend you taking any of my trades. I am not responsible for any of your profits or losses. This analysis is purely for entertainment only, and it represents what could happen with the stock.
Analysis like every analysis is never 100% accurate and it can easely go south because of the news we cannot control.
I post this analysis only for a idea.

If you would like to get funded account you can contact me. Not US residents.

Rene Pungartnik
blackstock

Comments

stock idea was not successful, because of the bad coronavirus and recovery news.
Reply